{"id":"https://openalex.org/W2042850239","doi":"https://doi.org/10.4103/0975-7406.106569","title":"Biosimilars: Current regulatory perspective and challenges","display_name":"Biosimilars: Current regulatory perspective and challenges","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2042850239","doi":"https://doi.org/10.4103/0975-7406.106569","mag":"2042850239","pmid":"https://pubmed.ncbi.nlm.nih.gov/23559830","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3612345"},"language":"en","primary_location":{"id":"doi:10.4103/0975-7406.106569","doi":"https://doi.org/10.4103/0975-7406.106569","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0975-7406.106569","pdf_url":null,"source":{"id":"https://openalex.org/S109681697","display_name":"Journal of Pharmacy And Bioallied Sciences","issn_l":"0975-7406","issn":["0975-7406","0976-4879"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy And Bioallied Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.4103/0975-7406.106569","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112338162","display_name":"Diwakar Jha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101034","display_name":"Birla Institute of Technology and Science - Hyderabad Campus","ror":"https://ror.org/014ctt859","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"id":"https://openalex.org/I4210139218","display_name":"Syneos Health (India)","ror":"https://ror.org/03fgnpp77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210139218"]},{"id":"https://openalex.org/I74796645","display_name":"Birla Institute of Technology and Science, Pilani","ror":"https://ror.org/001p3jz28","country_code":"IN","type":"education","lineage":["https://openalex.org/I74796645"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Diwakar Jha","raw_affiliation_strings":["Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: djhaag@rediffmail.com","1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: djhaag@rediffmail.com","institution_ids":["https://openalex.org/I4210139218"]},{"raw_affiliation_string":"1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"raw_affiliation_string":"Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210139218"]},{"raw_affiliation_string":"This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057359487","display_name":"Ram Kumar Mishra","orcid":"https://orcid.org/0000-0002-0977-0162","observed_orcids":["https://orcid.org/0000-0002-0977-0162"]},"institutions":[{"id":"https://openalex.org/I4210101034","display_name":"Birla Institute of Technology and Science - Hyderabad Campus","ror":"https://ror.org/014ctt859","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"id":"https://openalex.org/I4210139218","display_name":"Syneos Health (India)","ror":"https://ror.org/03fgnpp77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210139218"]},{"id":"https://openalex.org/I74796645","display_name":"Birla Institute of Technology and Science, Pilani","ror":"https://ror.org/001p3jz28","country_code":"IN","type":"education","lineage":["https://openalex.org/I74796645"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"RamKumar Mishra","raw_affiliation_strings":["Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210139218"]},{"raw_affiliation_string":"1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"raw_affiliation_string":"This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Rishabh Pandey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101034","display_name":"Birla Institute of Technology and Science - Hyderabad Campus","ror":"https://ror.org/014ctt859","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"id":"https://openalex.org/I4210139218","display_name":"Syneos Health (India)","ror":"https://ror.org/03fgnpp77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210139218"]},{"id":"https://openalex.org/I74796645","display_name":"Birla Institute of Technology and Science, Pilani","ror":"https://ror.org/001p3jz28","country_code":"IN","type":"education","lineage":["https://openalex.org/I74796645"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rishabh Pandey","raw_affiliation_strings":["Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Information and Scientific Affairs, Inventiv-I3, Gurgaon, India E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210139218"]},{"raw_affiliation_string":"1Department of Pharmacy, Birla Institute of Technology and Sciences - Pilani, Hyderabad Campus, R. R. District Hyderabad, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210101034","https://openalex.org/I74796645"]},{"raw_affiliation_string":"This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":250,"currency":"USD","value_usd":250},"apc_paid":{"value":250,"currency":"USD","value_usd":250},"fwci":0.1437,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.53132306,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"1","first_page":"80","last_page":"80"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9990000128746033},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.6819999814033508},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.7639999985694885},{"id":"https://openalex.org/keywords/reference-products","display_name":"reference products","score":0.4410000145435333},{"id":"https://openalex.org/keywords/protein-drugs","display_name":"protein drugs","score":0.367000013589859},{"id":"https://openalex.org/keywords/glycosylation","display_name":"glycosylation","score":0.5019999742507935},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.37700000405311584},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.9070000052452087},{"id":"https://openalex.org/keywords/recombinant-human-growth-hormone","display_name":"recombinant human growth hormone","score":0.6240000128746033},{"id":"https://openalex.org/keywords/quality-safety-and-efficacy","display_name":"quality, safety and efficacy","score":0.5839999914169312},{"id":"https://openalex.org/keywords/biogenerics","display_name":"biogenerics","score":0.4659999907016754},{"id":"https://openalex.org/keywords/analytical-characterization","display_name":"analytical characterization","score":0.414000004529953},{"id":"https://openalex.org/keywords/immunoglobulins","display_name":"immunoglobulins","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9835693836212158},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.41860872507095337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41829633712768555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4113794267177582},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.36210790276527405},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.1421758234500885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12251797318458557}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.4103/0975-7406.106569","doi":"https://doi.org/10.4103/0975-7406.106569","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0975-7406.106569","pdf_url":null,"source":{"id":"https://openalex.org/S109681697","display_name":"Journal of Pharmacy And Bioallied Sciences","issn_l":"0975-7406","issn":["0975-7406","0976-4879"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy And Bioallied Sciences","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2615946","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3612345","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3612345","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3612345","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pharm Bioallied Sci","raw_type":"Text"},{"id":"pmid:23559830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23559830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & bioallied sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:dd3a6b567aaf4c1baf537b2f398267f0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dd3a6b567aaf4c1baf537b2f398267f0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacy and Bioallied Sciences, Vol 5, Iss 1, Pp 80-81 (2013)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.4103/0975-7406.106569","doi":"https://doi.org/10.4103/0975-7406.106569","is_oa":true,"landing_page_url":"https://doi.org/10.4103/0975-7406.106569","pdf_url":null,"source":{"id":"https://openalex.org/S109681697","display_name":"Journal of Pharmacy And Bioallied Sciences","issn_l":"0975-7406","issn":["0975-7406","0976-4879"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy And Bioallied Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.41100001335144043,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1966790580","https://openalex.org/W2332671719"],"related_works":["https://openalex.org/W4253199625","https://openalex.org/W2114127266","https://openalex.org/W1488809091","https://openalex.org/W7221366417","https://openalex.org/W2133491755","https://openalex.org/W2118453167","https://openalex.org/W2332375904","https://openalex.org/W7201873404","https://openalex.org/W4297910132","https://openalex.org/W2759170843"],"abstract_inverted_index":{"Sir,":[0],"Biosimilars\u2014the":[1],"generic":[2],"version":[3],"of":[4,18,62,96,101,131,147,168,174,208,220,233,256,313,433,458,475,503,505,513,553],"biologicals":[5,55,549],"is":[6,22,435,478,542],"the":[7,20,54,57,159,231,254,262,317,490,506,523,538],"new":[8],"buzz":[9],"word":[10],"in":[11,42,60,93,104,108,115,176,187,194,259,310,326,332,383,388,405,485],"pharmaceutical":[12],"industry.":[13],"With":[14,301],"annual":[15],"growth":[16,72,444],"rate":[17],"7%,":[19],"sector":[21],"expected":[23],"to":[24,26,35,164,191,213,362,418,438,534],"grow":[25],"$172":[27],"billion":[28,92,103,107],"by":[29,144,261,272,329,370,498],"2015.[1]":[30],"Biosimilars":[31,487],"are":[32,48,133,287,307,356,422],"highly":[33],"similar":[34],"licensed":[36],"reference":[37,58,439,507],"product":[38,59,508,516,528],"notwithstanding":[39],"minor":[40],"differences":[41,52,186],"clinically":[43,50],"inactive":[44],"components;":[45],"also":[46],"there":[47,306],"no":[49,308],"meaningful":[51],"between":[53],"and":[56,65,74,78,121,128,142,170,197,243,283,299,322,335,350,359,428,451,480,544],"terms":[61],"safety,":[63,424],"purity,":[64],"potency.":[66],"Beginning":[67],"with":[68,138,179,390,537],"human":[69,71,290],"insulin,":[70,292],"hormone,":[73,445],"erythropoietin":[75,88],"(1982,":[76],"1985,":[77],"1989)":[79],">200":[80],"biosimilars":[81,277,421,434,459],"have":[82,489],"hit":[83],"market.":[84],"The":[85,205,354,415,430,456,473],"market":[86,100],"for":[87,223,226,246,253,281,289,378,402,442,482,526],"was":[89,368,407],"worth":[90],"$13":[91],"2011,":[94,266],"ahead":[95],"Lipitor":[97],"which":[98,447],"had":[99,448],"$12.4":[102],"2008":[105],"($12.4":[106],"2011).[2]":[109],"Biologicals":[110],"differ":[111],"from":[112,218,412,453],"conventional":[113],"generics":[114],"size,":[116],"structure,":[117],"stability,":[118],"in-built":[119],"heterogeneity,":[120],"analytical":[122],"characterization.":[123],"Their":[124],"unique":[125],"multidimensional":[126],"structure":[127],"complicated":[129],"mode":[130],"action":[132],"never":[134],"fully":[135,279,462],"reproducible.":[136],"Even":[137],"same":[139,145,240,491],"molecular":[140],"weight":[141],"production":[143],"type":[146],"cells,":[148],"they":[149],"possess":[150],"different":[151,449,543],"properties,":[152],"e.g.,":[153],"European":[154,263],"Medicines":[155],"Agency":[156],"(EMEA)":[157],"rejected":[158],"biosimilar":[160,348,443],"Alpheon":[161,180],"(interferon-oL)":[162],"due":[163],"a":[165],"higher":[166],"number":[167],"AEs":[169],"more":[171],"frequent":[172],"recurrence":[173],"disease":[175],"patients":[177],"treated":[178],"than":[181],"reference\u2013Roferon-A.":[182],"For":[183],"immunoglobulins,":[184],"small":[185],"core":[188],"fucosylation":[189],"led":[190],"big":[192],"changes":[193,484],"receptor":[195],"binding":[196],"consequently":[198],"impacted":[199],"immune":[200],"functions":[201],"like":[202],"cellular":[203],"cytotoxicity.[2]":[204],"classical":[206],"paradigm":[207],"bioequivalence":[209],"cannot":[210,375,460,488,530],"be":[211,278,376,461],"applied":[212],"protein":[214],"drugs":[215],"as":[216,303,440,495],"evident":[217],"case":[219,361],"Retacrit.":[221],"EMEA/Committee":[222],"Medicinal":[224],"Products":[225],"Human":[227],"Use":[228],"(CHMP)":[229],"burgeoned":[230],"concept":[232,533],"biosimilarity.":[234],"Biosimilars\u2019":[235],"approval":[236,255],"should":[237,547],"consider":[238,419],"exactly":[239],"high":[241],"standards":[242],"stringent":[244],"requirements":[245],"quality,":[247],"efficacy,":[248],"or":[249],"safety.":[250],"First":[251],"recommendation":[252],"biogenerics":[257],"came":[258],"2004":[260],"Parliament.":[264],"By":[265],"14":[267],"marketing":[268,385],"authorizations":[269,386],"were":[270,387],"made":[271],"EMEA.":[273],"EMEA":[274,318,341],"lays":[275],"that":[276],"characterized":[280],"physicochemical":[282],"biophysical":[284],"attributes.[3]":[285],"Guidelines":[286],"laid":[288],"soluble":[291],"somatropin,":[293],"granulocyte":[294],"colony":[295],"stimulating":[296],"factor":[297],"(G-CSF),":[298],"epoetins.":[300],"France":[302],"only":[304],"exception,":[305],"regulations":[309],"other":[311,379],"countries":[312],"EU.":[314],"Australia":[315],"adopted":[316],"guidelines,":[319],"whereas":[320],"Japan":[321],"Singapore":[323],"issued":[324],"guidelines":[325,355],"2009,":[327],"followed":[328],"Health":[330],"Canada":[331],"2010.":[333],"WHO":[334],"some":[336],"national":[337],"guidance":[338],"documents":[339],"recommend":[340],"approaches.":[342],"FDA":[343],"recommends":[344],"two":[345],"approaches:":[346],"(1)":[347],"approach":[349,500],"(2)":[351],"stand-alone":[352],"approach.":[353,392],"under":[357],"construction":[358],"vary":[360],"case.":[363],"Sandoz's":[364],"somatropin":[365],"product,":[366],"Omnitrope,":[367],"approved":[369],"FDA,":[371],"but":[372,509,529],"this":[373,532],"pathway":[374],"used":[377],"products.[4]":[380],"Till":[381],"recently":[382],"India,":[384],"line":[389],"US":[391],"In":[393],"July":[394],"2012,":[395],"\u201cGuidelines":[396],"on":[397],"Similar":[398],"Biologics:":[399],"Regulatory":[400],"Requirements":[401],"Marketing":[403],"Authorization":[404],"India\u201d":[406],"introduced.":[408],"It":[409],"draws":[410],"cues":[411],"EMEA/ICH":[413],"guidelines.[5]":[414],"main":[416],"points":[417],"about":[420],"their":[423],"automatic":[425],"substitution,":[426],"naming,":[427],"labeling/prescription.":[429],"safety":[431],"profile":[432],"not":[436],"identical":[437],"seen":[441],"Valtropin,":[446],"precautions":[450],"warnings":[452],"reference,":[454],"Humatrope.":[455],"immunogenicity":[457],"predicted":[463],"using":[464],"preclinical/clinical":[465],"studies.":[466],"Robust":[467],"pharmacovigilance":[468],"still":[469],"remains":[470],"critical":[471,511],"consideration.":[472],"story":[474],"epoetin":[476],"therapy":[477],"instructive":[479],"called":[481],"subtle":[483],"manufacturing.":[486],"international":[492],"non-proprietary":[493],"name":[494],"innovator.":[496],"\u201cQuality":[497],"design\u201d":[499],"provides":[501],"assurance":[502],"quality":[504],"requires":[510],"understanding":[512],"variability":[514],"ofevery":[515],"attribute.":[517],"A":[518],"manufacturer":[519],"may":[520],"well":[521],"establish":[522],"design":[524],"space":[525],"his":[527],"use":[531],"ensure":[535],"similarity":[536],"reference.":[539],"Every":[540],"biological":[541],"healthcare":[545],"professionals":[546],"interchange":[548],"after":[550],"careful":[551],"analysis":[552],"supporting":[554],"data.[2]":[555]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}